News
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
1don MSN
There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of ...
5d
24/7 Wall St. on MSNPfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...
Insider Monkey on MSN10d
Is Pfizer Inc. (PFE) The Most Profitable Cheap Stock to Buy Now?We recently compiled a list of the 10 Most Profitable Cheap Stocks to Buy Now. In this article, we are going to take a look ...
With its stock down 7.6% over the past three months, it is easy to disregard Pfizer (NYSE:PFE). We, however decided ...
PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 95% based on the firm’s underlying fundamentals and the stock’s valuation.
7d
24/7 Wall St. on MSN3 Ultra-High Yield Dividend Stocks to Buy This MayAmid the ongoing uncertainty about tariffs, muted earnings season, and recession concerns, the stock market has remained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results